RAVI M. SHANKER

Solubility advantage of amorphous pharmaceuticals, part 3: Is maximum solubility advantage experimentally attainable and sustainable?

M. Pikal, R. Shanker, R. Bogner, 2011, Journal of pharmaceutical sciences.